Medpace Holdings, Inc. Long-term Line of Credit
Medpace Holdings, Inc. (MEDP) had Long-term Line of Credit of $50.00 million as of 2022-12-31, per its 10-K filed 2023-02-14.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LineOfCredit · last filed 2023-02-14
- 2022-12-31: Long-term Line of Credit $50.00M.
- 2022-09-30: Long-term Line of Credit $139.70M.
- 2022-06-30: Long-term Line of Credit $249.70M.
- 2021-12-31: Long-term Line of Credit $0.00.
| Period end | Long-term Line of Credit |
|---|---|
| 2022-12-31 | $50.00M 10-K · filed 2023-02-14 |
| 2022-09-30 | $139.70M 10-Q · filed 2022-10-25 |
| 2022-06-30 | $249.70M 10-Q · filed 2022-07-26 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |